Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Since their introduction in clinical practice in the 1950's, Sulfonylureas (SUs) have remained the main-stay of pharmacotherapy in the management of type 2 diabetes. Despite their well-established benefits, their place in therapy is inappropriately being overshadowed by newer therapies. Many of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Endocrinol Metab
Main Authors: Kalra, Sanjay, Aamir, A. H., Raza, Abbas, Das, A. K., Azad Khan, A. K., Shrestha, Dina, Qureshi, Md Faisal, Md Fariduddin, Pathan, Md Faruque, Jawad, Fatema, Bhattarai, Jyoti, Tandon, Nikhil, Somasundaram, Noel, Katulanda, Prasad, Sahay, Rakesh, Dhungel, Sanjib, Bajaj, Sarita, Chowdhury, Subhankar, Ghosh, Sujoy, Madhu, S. V., Ahmed, Tofail, Bulughapitiya, Uditha
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2015
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4566336/
https://ncbi.nlm.nih.gov/pubmed/26425465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.163171
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados